Moolec Science (MLEC) Consolidated Net Income (2022 - 2024)
Moolec Science (MLEC) reported Consolidated Net Income of -$2.4 million for Q4 2024, down 36.1% on a YoY basis from -$3.8 million in Q1 2024, and down 26.72% sequentially from -$1.9 million in Q3 2024.
Moolec Science (MLEC) Consolidated Net Income (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Consolidated Net Income data on file, last reported at -$2.4 million in Q4 2024.
- For the quarter ending Q4 2024, Consolidated Net Income fell 36.1% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$2.4 million (changed N/A YoY), and the FY2024 full-year result was -$7.3 million, up 85.88% from the prior year.
- Consolidated Net Income retreated to -$2.4 million in Q4 2024, from -$1.9 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$358578.0 in Q1 2023 to a low of -$48.0 million in Q4 2022.
- A 3-year average of -$5.5 million and a median of -$1.7 million in 2023 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income surged 96.28% in 2023 and plunged 291.05% in 2024, its largest moves.
- Tracing MLEC's Consolidated Net Income over 3 years: stood at -$48.0 million in 2022, then surged by 96.28% to -$1.8 million in 2023, then plunged by 36.1% to -$2.4 million in 2024.
- Business Quant data shows MLEC's Consolidated Net Income at -$2.4 million in Q4 2024, -$1.9 million in Q3 2024, and -$2.5 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -2.54 Mn |
| Mar 31, 2024 | -1.40 Mn |
| Dec 31, 2023 | -1.78 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -2.98 Mn |
| Mar 31, 2023 | -358,578.00 |
| Dec 31, 2022 | -47.96 Mn |
| Sep 30, 2022 | -721,426.00 |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -1.17 Mn |